A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
A Phase 3a, Observer-blind, Randomized, Controlled Study to Evaluate the Safety of an Investigational Varicella Vaccine Compared With Varivax, Administered as a First Dose to Healthy Children 12 to 15 Months of Age
Sponsor: GlaxoSmithKline
A PHASE3 clinical study on Chickenpox, this trial is actively recruiting participants. The trial is conducted by GlaxoSmithKline and has accumulated 2 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
2 versions recorded-
Feb 2025 — Present [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Dec 2024 — Feb 2025 [monthly]
Not Yet Recruiting PHASE3
First recorded
Nov 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
For direct contact, visit the study record on ClinicalTrials.gov .